Uzbekistan Children Death Case: Indian Pharma’s Cough Syrup Under Scanner

Uzbekistan links deaths
of 18 kids to cough syrup
from India

About 18 children died in Uzbekistan after allegedly consuming syrup manufactured by Indian pharmaceutical company Marion Biotech, the Uzbekistan Health Ministry has claimed

Dok-1 Max syrup
produced by Noida-based
Marion Biotech

The Uzbekistan Health Ministry said that the children died as a result of consuming the Dok-1 Max syrup, produced by Noida-based Marion Biotech and imported into Uzbekistan by Quramax Medical. So far, 18 out of 21 children with acute respiratory disease have died after taking the cough syrup

Probe reveals
presence of chemical
'ethylene glycol'

According to reports, the chemical ethylene glycol was found in the Dok-1 Max syrup. The substance is believed to be toxic and can lead to serious changes in a patient's health

'Syrup given without a
doctor's prescription'

Uzbekistan's health ministry said that the syrup was given to the children without a doctor's prescription. It was identified that the children, before being hospitalised, took this syrup at home for 2-7 days, in doses of 2.5 to 5 ml three to four times a day

'Syrup used as
anti-cold remedy'

It is believed that the Doc-1 Max syrup was used by the parents as an anti-cold remedy as the main component of the drug is paracetamol. Parents used the drug either on their own or on the recommendation of pharmacy sellers

Doc-1 Max tablets and
syrups withdrawn

Doc-1 Max tablets and syrups were withdrawn from all pharmacies in the central Asian country after the incident occurred. Moreover, seven employees have reportedly been sacked due to negligence

Joint inquiry in Uzbekistan
cough syrup death case 

A joint inquiry is being conducted by the Central Drugs Standard Control Organisation (CDSCO) teams and Uttar Pradesh Drugs Controlling and Licensing Authority in the case

Dok-1 max syrup
unavailable in Indian
market

Sources in the Central Drugs Standard Control Organisation (CDSCO) told India Today that this particular syrup is currently not being sold in the Indian market

A look back at Maiden
Pharma Row

A similar incident grabbed the spotlight earlier in 2022. Haryana-based Maiden Pharmaceuticals came under the scanner after the deaths of 70 children in Gambia were linked to cough syrups manufactured by the company

Viral Video: Mid-Air Fight On Bangkok To India Flight

Next Visual Story 

Produced By: Smriti
Designed By: Mohsin

Click Here

Next: People To Watch Out For In 2023: Nirmala Sitharaman, Gautam Adani, Mukesh Ambani, Musk